Top Brand
Our Recommendation
944+ trust this
WHO GMP Certified
944+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Type 2 diabetes mellitus Valera Tablet belongs to a group of medicines called DPP-4 inhibitors (or gliptins). It helps increase the amount of insulin your body produces after a meal and to stop your body from releasing too much glucose (sugar) into your blood. This way it lowers the blood glucose levels in your body. It is usually taken once a day and has relatively few common side effects. Lowering blood glucose levels is an essential part of managing diabetes. Controlling the blood glucose level helps prevent serious complications of diabetes such as kidney damage, blindness, and loss of limbs. Proper control of diabetes can also reduce the risk of heart disease and stroke. Taking this medicine regularly along with a proper program of diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed for long-term benefits.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Valera Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
Valera Tablet is an anti-diabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Valera Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Valera Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Valera Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
SAFE - Valera Tablet does not usually affect your ability to drive. However, patients should be alerted to the risk of hypoglycemia especially when Valera Tablet is coadministered with sulfonylurea and/or insulin.
Caution Advised: Valera Tablet should be used with caution in patients with kidney disease. Dose adjustment of Valera Tablet may be needed. Doctor consultation is advised. However, the use of Valera Tablet is not recommended in patients with end-stage kidney disease requiring dialysis due to a lack of clinical data.
Safe when prescribed by an expert: Valera Tablet is safe to use in patients with liver disease. No dose adjustment of Valera Tablet is recommended. However, caution should be exercised in patients with severe liver disease as there are no clinical data about its use in such cases.
If a dose of Valera Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.
Evogliptin (8 Oct. 2021)
Dutta D, Bhattacharya S, Krishnamurthy A, et al. Efficacy and Safety of Novel Dipeptidyl-Peptidase-4 Inhibitor Evogliptin in the Management of Type 2 Diabetes Mellitus: A Meta-Analysis. Indian J Endocrinol Metab. 2020;24(5):434-445 (8 Oct. 2021)
Park J, Park SW, Yoon KH, et al. Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise. Diabetes Obes Metab. 2017;19(12):1681-87 (30 Jan. 2020)
Evogliptin (24 June 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.